463 related articles for article (PubMed ID: 32516961)
1. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases.
Bhat MA; Ahmad K; Khan MSA; Bhat MA; Almatroudi A; Rahman S; Jan AT
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32516961
[TBL] [Abstract][Full Text] [Related]
2. Taurine and its neuroprotective role.
Kumari N; Prentice H; Wu JY
Adv Exp Med Biol; 2013; 775():19-27. PubMed ID: 23392921
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
4. Targeting endoplasmic reticulum stress and autophagy as therapeutic approaches for neurological diseases.
Thangaraj A; Sil S; Tripathi A; Chivero ET; Periyasamy P; Buch S
Int Rev Cell Mol Biol; 2020; 350():285-325. PubMed ID: 32138902
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Gharibani PM; Modi J; Pan C; Menzie J; Ma Z; Chen PC; Tao R; Prentice H; Wu JY
Adv Exp Med Biol; 2013; 776():241-58. PubMed ID: 23392887
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying taurine protection against glutamate-induced neurotoxicity.
Ye HB; Shi HB; Yin SK
Can J Neurol Sci; 2013 Sep; 40(5):628-34. PubMed ID: 23968934
[TBL] [Abstract][Full Text] [Related]
7. Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.
Chopra G; Shabir S; Yousuf S; Kauts S; Bhat SA; Mir AH; Singh MP
Mol Neurobiol; 2022 Dec; 59(12):7513-7540. PubMed ID: 36205914
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Neuronal Protection against Excitotoxicity, Endoplasmic Reticulum Stress, and Mitochondrial Dysfunction in Stroke and Neurodegenerative Diseases.
Prentice H; Modi JP; Wu JY
Oxid Med Cell Longev; 2015; 2015():964518. PubMed ID: 26576229
[TBL] [Abstract][Full Text] [Related]
9. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
Soto C; Pritzkow S
Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
[TBL] [Abstract][Full Text] [Related]
10. Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
Fan HC; Chi CS; Cheng SN; Lee HF; Tsai JD; Lin SZ; Harn HJ
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712747
[TBL] [Abstract][Full Text] [Related]
11. Taurine resumed neuronal differentiation in arsenite-treated N2a cells through reducing oxidative stress, endoplasmic reticulum stress, and mitochondrial dysfunction.
Chou CT; Lin HT; Hwang PA; Wang ST; Hsieh CH; Hwang DF
Amino Acids; 2015 Apr; 47(4):735-44. PubMed ID: 25547999
[TBL] [Abstract][Full Text] [Related]
12. Unfolded Protein Response Pathways in Neurodegenerative Diseases.
Shah SZ; Zhao D; Khan SH; Yang L
J Mol Neurosci; 2015 Dec; 57(4):529-37. PubMed ID: 26304853
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism aspect of ER stress in Alzheimer's disease: current approaches and future strategies.
Ansari N; Khodagholi F
Curr Drug Targets; 2013 Jan; 14(1):114-22. PubMed ID: 23016524
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK).
Taalab YM; Ibrahim N; Maher A; Hassan M; Mohamed W; Moustafa AA; Salama M; Johar D; Bernstein L
Rev Neurosci; 2018 Jun; 29(4):387-415. PubMed ID: 29303785
[TBL] [Abstract][Full Text] [Related]
15. Protection of differentiated neuronal NG108-15 cells from P2X7 receptor-mediated toxicity by taurine.
Chao CC; Chan P; Kuo CS; Gong CL; Cheng TH; Liu ZM; Shen PC; Huang CC; Leung YM
Pharmacol Rep; 2014 Aug; 66(4):576-84. PubMed ID: 24948057
[TBL] [Abstract][Full Text] [Related]
16. The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases.
Santa-Cecília FV; Leite CA; Del-Bel E; Raisman-Vozari R
Neurotox Res; 2019 May; 35(4):981-986. PubMed ID: 30798507
[TBL] [Abstract][Full Text] [Related]
17. PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders.
Tomoshige S; Ishikawa M
Angew Chem Int Ed Engl; 2021 Feb; 60(7):3346-3354. PubMed ID: 32410219
[TBL] [Abstract][Full Text] [Related]
18. ER stress and the unfolded protein response in neurodegeneration.
Hetz C; Saxena S
Nat Rev Neurol; 2017 Aug; 13(8):477-491. PubMed ID: 28731040
[TBL] [Abstract][Full Text] [Related]
19. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
Bobori C; Theocharopoulou G; Vlamos P
Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological studies on neurodegenerative diseases focusing on refolding and degradation of unfolded proteins in the endoplasmic reticulum].
Nomura Y
Yakugaku Zasshi; 2014; 134(4):537-43. PubMed ID: 24694815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
